On Wednesday, Shares of Microsoft Corporation (NASDAQ:MSFT), gained 2.19% to $47.61.
Microsoft Corporation, hired Casey Hudson, the prolific director of Electronic Arts, and Bioware’s Mass Effect trilogy, as the new creative director of Microsoft Studios. Hudson will work on forthcoming HoloLens and Xbox games alongside John Needham, the former head of Fable developer Lionhead Studios.
In an interview with Microsoft’s Xbox Wire, Hudson said that his primary focus would be “the creative direction of HoloLens Experiences,” which overlay digital content on top of real-world objects. Hudson stated that the “mixed reality and holographic computing will have a tremendous impact on how all of us interact with technology.”
Microsoft Corporation develops, licenses, markets, and supports software, services, and devices worldwide. The company’s Devices and Consumer (D&C) Licensing segment licenses Windows operating system and related software; Microsoft Office for consumers; and Windows Phone operating system.
Shares of Hewlett-Packard Company (NYSE:HPQ), inclined 1.20% to $33.78, during its last trading session.
Hewlett-Packard Company, board of directors has declared a regular cash dividend of $0.176 per share on the company’s common stock.
The dividend, the third in HP’s fiscal year 2015, is payable on July 1, 2015, to stockholders of record as of the close of business on June 10, 2015.
HP has about 1.8 billion shares of common stock outstanding.
Hewlett-Packard Company, together with its auxiliaries, provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses (SMBs), in addition to to the government, health, and education sectors worldwide.
At the end of Wednesday’s trade, Shares of Delcath Systems, Inc. (NASDAQ:DCTH), skyrocketed 66.94% to $1.42.
Delcath Systems, declared findings from its recent three-day Key Opinion Leader Forum that focused on CHEMOSAT®, the Company’s percutaneous hepatic perfusion (PHP) therapy for the treatment of liver cancers. The Forum took place near Paris and comprised of more than 20 medical specialists in oncology, surgical oncology, anesthesiology and interventional radiology from across Europe where CHEMOSAT is commercially accessible. CHEMOSAT is not commercially accessible in the US.
The Forum featured a discussion of hands-on commercial experiences with CHEMOSAT. Key findings from the Forum were:
- Clinicians continue to produce positive, life-extending results treating liver cancer patients with CHEMOSAT in multiple tumor types
- CHEMOSAT is well tolerated and is an easy-to-learn procedure for an practiced treatment team
- Multiple treatment courses of at least four procedures have been shown to be safe and well tolerated while ongoing to provide clinical benefit and good quality of life
- Reimbursement continues to be covered through individual funding requests
- Clinicians are encouraged by the potential for CHEMOSAT to treat many tumor types and support the generation of additional data in these potential indications.
Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Delivery System; and markets melphalan hydrochloride as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan in Europe.
Oil and gas stocks were among the biggest decliners as the price of oil fell sharply. Benchmark U.S. oil dropped $1.69, or 2.8 percent, to close at $58.03 a barrel on the New York Mercantile Exchange. Transocean, Valero Energy and Allegheny Technologies were all down 3 percent or more.
However, Denbury Resources Inc. (NYSE:DNR), ended its last trade with 1.11% gain, and closed at $7.26.
Denbury Resources Inc. operates as an independent oil and natural gas company in the United States. The company primarily focuses on improved oil recovery utilizing carbon dioxide. It holds properties located in Mississippi, Texas, Louisiana, and Alabama in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
